These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15905755)

  • 1. Promethazine for the treatment of agitation after electroconvulsive therapy: a case series.
    Vishne T; Amiaz R; Grunhaus L
    J ECT; 2005 Jun; 21(2):118-21. PubMed ID: 15905755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Premedication with dexmedetomidine and midazolam attenuates agitation after electroconvulsive therapy.
    Mizrak A; Koruk S; Ganidagli S; Bulut M; Oner U
    J Anesth; 2009; 23(1):6-10. PubMed ID: 19234815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Orally Disintegrating Olanzapine During Electroconvulsive Therapy for Prevention of Postictal Agitation.
    Hermida AP; Janjua AU; Tang Y; Syre SR; Job G; McDonald WM
    J Psychiatr Pract; 2016 Nov; 22(6):459-462. PubMed ID: 27824778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-electroconvulsive therapy agitation with etomidate.
    Freeman SA
    J ECT; 2009 Jun; 25(2):133-4. PubMed ID: 19494736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-ECT agitation and plasma lactate concentrations.
    Auriacombe M; Rénéric JP; Usandizaga D; Gomez F; Combourieu I; Tignol J
    J ECT; 2000 Sep; 16(3):263-7. PubMed ID: 11005048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rocuronium-sugammadex decreases the severity of post-electroconvulsive therapy agitation.
    Postaci A; Tiryaki C; Sacan O; Ornek D; Kalyoncu M; Dikmen B
    J ECT; 2013 Mar; 29(1):e2-3. PubMed ID: 23422529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Electroconvulsive Therapy in Dementia-Related Agitation: A Case Series.
    Burton MC; Koeller SL; Brekke FM; Afonya AT; Sutor B; Lapid MI
    J ECT; 2017 Dec; 33(4):286-289. PubMed ID: 28658012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical approach to agitation after electroconvulsive therapy: a case report and literature review.
    Augoustides JG; Greenblatt E; Abbas MA; O'Reardon JP; Datto CJ
    J ECT; 2002 Dec; 18(4):213-7. PubMed ID: 12468998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propofol for the management of emergence agitation after electroconvulsive therapy: review of a case series.
    O'Reardon JP; Takieddine N; Datto CJ; Augoustides JG
    J ECT; 2006 Dec; 22(4):247-52. PubMed ID: 17143155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of electroconvulsive therapy for the treatment of agitation and aggression in patients with dementia.
    Ujkaj M; Davidoff DA; Seiner SJ; Ellison JM; Harper DG; Forester BP
    Am J Geriatr Psychiatry; 2012 Jan; 20(1):61-72. PubMed ID: 22143072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postictal agitation after electroconvulsive therapy: incidence, severity, and propofol as a treatment option.
    Tzabazis A; Schmitt HJ; Ihmsen H; Schmidtlein M; Zimmermann R; Wielopolski J; Münster T
    J ECT; 2013 Sep; 29(3):189-95. PubMed ID: 23792779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electroconvulsive therapy (ECT) for treating agitation in dementia (major neurocognitive disorder) - a promising option.
    Glass OM; Forester BP; Hermida AP
    Int Psychogeriatr; 2017 May; 29(5):717-726. PubMed ID: 28095946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits of Dexmedetomidine in Management of Post-ECT Agitation.
    Narang P; Ianovich F; Sarai SK; Lippmann S
    J ECT; 2017 Sep; 33(3):150-151. PubMed ID: 28178037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electroconvulsive Therapy for Agitation and Aggression in Dementia: A Systematic Review.
    van den Berg JF; Kruithof HC; Kok RM; Verwijk E; Spaans HP
    Am J Geriatr Psychiatry; 2018 Apr; 26(4):419-434. PubMed ID: 29107460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Midazolam for treatment of agitation after ECT.
    Labbate LA; Miller JP
    Am J Psychiatry; 1995 Mar; 152(3):472-3. PubMed ID: 7864283
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and Safety of ECT for Behavioral and Psychological Symptoms of Dementia (BPSD): A Retrospective Chart Review.
    Hermida AP; Tang YL; Glass O; Janjua AU; McDonald WM
    Am J Geriatr Psychiatry; 2020 Feb; 28(2):157-163. PubMed ID: 31668364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of post-electroconvulsive therapy delirium and agitation with donepezil.
    Logan CJ; Stewart JT
    J ECT; 2007 Mar; 23(1):28-9. PubMed ID: 17435571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electroconvulsive therapy for agitation in Alzheimer disease: a case series.
    Sutor B; Rasmussen KG
    J ECT; 2008 Sep; 24(3):239-41. PubMed ID: 18562945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of promethazine on postoperative pain: a comparison of preoperative, postoperative, and placebo administration in patients following total abdominal hysterectomy.
    Chia YY; Lo Y; Liu K; Tan PH; Chung NC; Ko NH
    Acta Anaesthesiol Scand; 2004 May; 48(5):625-30. PubMed ID: 15101860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid tranquilization for agitated patients in emergency psychiatric rooms: a randomized trial of olanzapine, ziprasidone, haloperidol plus promethazine, haloperidol plus midazolam and haloperidol alone.
    Baldaçara L; Sanches M; Cordeiro DC; Jackoswski AP
    Braz J Psychiatry; 2011 Mar; 33(1):30-9. PubMed ID: 21537720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.